Literature DB >> 15725581

Complications of anaesthesia in neuromuscular disorders.

Werner Klingler1, Frank Lehmann-Horn, Karin Jurkat-Rott.   

Abstract

The purpose of this review is to alert non-anaesthesiologists to the various complications from which patients with neuromuscular disorders and those susceptible to malignant hyperthermia can suffer during anaesthesia. The patient's outcome correlates with the quality of consultation between anaesthesiologists, surgeons, neurologists and cardiologists. Special precautions must be taken, since many anaesthetics and muscle relaxants can aggravate the clinical features or trigger life-threatening reactions. Complications frequently occur in these patients, although anaesthetic procedures have become safer by the reduced administration of suxamethonium and the use of total intravenous anaesthesia, new volatile anaesthetics and non-depolarising relaxants. This review provides a synopsis of pre-operative anaesthetic considerations and adverse drug effects on skeletal, cardiac and smooth muscle tissue. It describes the pathogenetic aspects of typical complications and introduces anaesthetic procedures for the various neuromuscular disorders, including regional anaesthesia for patients in whom a restriction of respiratory and/or cardiac function is predicted.

Entities:  

Mesh:

Year:  2005        PMID: 15725581     DOI: 10.1016/j.nmd.2004.10.017

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

Review 1.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

2.  Orthognathic surgery in a case of infantile facioscapulohumeral muscular dystrophy with macroglossia.

Authors:  Marcus Stephan Kriwalsky; Marcus Deschauer; Alexander Walter Eckert; Johannes Schubert; Stephan Zierz
Journal:  Oral Maxillofac Surg       Date:  2008-12

3.  [Hotline for malignant hyperthermia. New telephone number for the German nationwide 24 h service center: 08221/9600].

Authors:  W Klingler; F Lehmann-Horn; U Schulte-Sasse
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

4.  [Muscle channelopathies. Myotonias and periodic paralyses].

Authors:  K Jurkat-Rott; H Lerche; F Lehmann-Horn
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 5.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 6.  Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 7.  [Pharmacogenetics in anesthesia and intensive care medicine : Clinical and legal challenges exemplified by malignant hyperthermia].

Authors:  W Klingler; E Pfenninger
Journal:  Anaesthesist       Date:  2016-05       Impact factor: 1.041

Review 8.  Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era.

Authors:  Yung-Hao Tseng; Tai-Heng Chen
Journal:  Front Neurol       Date:  2021-03-24       Impact factor: 4.003

Review 9.  Anaesthesia and neuromuscular disorders: what a neurologist needs to know.

Authors:  Heinz Jungbluth; Nicol C Voermans; Luuk R van den Bersselaar; Marc M J Snoeck; Madelief Gubbels; Sheila Riazi; Erik-Jan Kamsteeg
Journal:  Pract Neurol       Date:  2020-10-27

10.  Incidence of Unintentional Intraoperative Hypothermia in Pediatric Scoliosis Surgery and Associated Preoperative Risk Factors.

Authors:  Maho Okamura; Wataru Saito; Masayuki Miyagi; Eiki Shirasawa; Takayuki Imura; Toshiyuki Nakazawa; Yusuke Mimura; Yuji Yokozeki; Akiyoshi Kuroda; Ayumu Kawakubo; Kentaro Uchida; Tsutomu Akazawa; Masashi Takaso; Gen Inoue
Journal:  Spine Surg Relat Res       Date:  2020-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.